IDYA IDEAYA Biosciences, Inc.
Healthcare$29.38+0.00%OpenMarket Cap: $2.58B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$58.67
Target (Median)
$58.00
Target Range
$53.00 - $65.00
Upside from current price: 99.7%
Rating Distribution
3 Strong Buy13 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Mizuho | maintain | Outperform | Outperform |
| 2026-04-14 | Guggenheim | maintain | Buy | Buy |
| 2026-04-14 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-14 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-14 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-14 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-02-19 | Citigroup | maintain | Buy | Buy |
| 2026-02-18 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-18 | Guggenheim | maintain | Buy | Buy |
| 2026-02-18 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.74 | $115.2M | 12 |
| Sun Dec 31 | $-2.90 | $267.8M | 11 |
| Mon Dec 31 | $-0.78 | $584.9M | 4 |
| Tue Dec 31 | $2.12 | $1.03B | 4 |